Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Gemcitabine Hcl Taj Pharmaceuticals Ltd

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Gemcitabine Hcl Manufacturers in India Suppliers Gemcitabine Hcl Exporters Distributors Gemcitabine Hcl api active pharmaceuticals ingredients Gemcitabine Hcl manufacturers Side Effects bulk drugs raw material Gemcitabine Hcl companies Side Effects Importers Gemcitabine Hcl Gemcitabine Hcl Exporters Gemcitabine Hcl exporters FDA Gemcitabine Hcl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Gemcitabine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Gemcitabine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Gemcitabine Hydrochloride active pharmaceutical ingredients Gemcitabine Hydrochloride committee active pharmaceutical ingredients manufacturer Gemcitabine Hydrochloride Active Pharmaceutical Ingredients manufacturer Gemcitabine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Gemcitabine Hcl, Gemcitabine Hcl manufacturer India, Gemcitabine Hcl product, Gemcitabine Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Gemcitabine Hcl anti ulcer product, Certificate of Origin COA Gemcitabine Hcl COS Gemcitabine Hcl, pharmaceutical generic, pharmaceutical drug, medical, Gemcitabine Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Gemcitabine Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Gemcitabine Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Gemcitabine Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Gemcitabine Hcl ingredients, api, HIV Gemcitabine Hcl, tablets, capsules, syrup & protein Gemcitabine Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Gemcitabine Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Gemcitabine Hcl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Gemcitabine Hcl



































 

HOME >> API >> API List 2 >> Gemcitabine Hcl >> Side Effect

Gemcitabine Hcl  CAS Registry Number 122111-03-9

SIDE EFFECTS
Gemcitabine hydrochloride CAS Registry Number 122111-03-9

Some side effects are normal while taking Gemcitabine, such as nausea, vomiting, or pain/redness at the injection site, hair loss etc. However, if any of these effects worsen, contact your doctor promptly. Certain serious side effects also occur which require immediate medical attention, like

* Diarrhea
* Mouth sores
* Constipation
* Chills
* Fever
* Cough
* Unusual bleeding or bruising
* Loss of appetite
* Blood in the urine
* Yellowing eyes or skin
* Irregular heartbeat
* Change in the amount of urine
* Dark urine etc.

Each person’s reaction to chemotherapy is different. Some people have very few side effects, while others may experience more. The side effects described in this information will not affect everyone who is given gemcitabine, and may be different if you are having more than one chemotherapy drug.

We have outlined the most common side effects and some of the less common ones, so that you can be aware of them if they occur. However, we have not included those that are very rare and therefore extremely unlikely to affect you. If you notice any effects which you think may be due to the drug, but which are not listed in this information, please discuss them with your doctor or chemotherapy nurse.

Lowered resistance to infection Gemcitabine can reduce the production of white blood cells by the bone marrow, making you more prone to infection. This effect can begin seven days after treatment has been given, and your resistance to infection usually reaches its lowest point 10–14 days after chemotherapy. Your blood cells will then increase steadily, and will usually have returned to normal levels before your next course of chemotherapy is due.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS >>
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo
 

Gemcitabine Hcl

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.